Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Infusion Systems Market by Type (General purpose or volumetric pumps, Syringe drivers, Patient controlled analgesia pumps, Ambulatory pumps), By Application (Analgesia or pain management, Diabetes, Oncology, Gastroenterology, Hematology, Pediatric or neonatology) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Infusion Systems Market by Type (General purpose or volumetric pumps, Syringe drivers, Patient controlled analgesia pumps, Ambulatory pumps), By Application (Analgesia or pain management, Diabetes, Oncology, Gastroenterology, Hematology, Pediatric or neonatology) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131775 3300 Medical Devices & Consumables 377 241 Pages 4.8 (47)
                                          

Industry Growth Insights published a new data on “Infusion Systems Market”. The research report is titled “Infusion Systems Market research by Types (General purpose or volumetric pumps, Syringe drivers, Patient controlled analgesia pumps, Ambulatory pumps), By Applications (Analgesia or pain management, Diabetes, Oncology, Gastroenterology, Hematology, Pediatric or neonatology), By Players/Companies Competitive scenario, B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, Terumo”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Infusion Systems Market Research Report

By Type

General purpose or volumetric pumps, Syringe drivers, Patient controlled analgesia pumps, Ambulatory pumps

By Application

Analgesia or pain management, Diabetes, Oncology, Gastroenterology, Hematology, Pediatric or neonatology

By Companies

Competitive scenario, B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, Terumo

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

241

Number of Tables & Figures

169

Customization Available

Yes, the report can be customized as per your need.


Global Infusion Systems Industry Outlook


Global Infusion Systems Market Report Segments:

The global Infusion Systems market is segmented on the basis of:

Types

General purpose or volumetric pumps, Syringe drivers, Patient controlled analgesia pumps, Ambulatory pumps

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Analgesia or pain management, Diabetes, Oncology, Gastroenterology, Hematology, Pediatric or neonatology

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Competitive scenario
  2. B. Braun Melsungen
  3. Baxter
  4. BD
  5. Fresenius Kabi
  6. Hospira
  7. JMS
  8. Nipro
  9. Terumo

Global Infusion Systems Market Overview


Highlights of The Infusion Systems Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. General purpose or volumetric pumps
    2. Syringe drivers
    3. Patient controlled analgesia pumps
    4. Ambulatory pumps
  1. By Application:

    1. Analgesia or pain management
    2. Diabetes
    3. Oncology
    4. Gastroenterology
    5. Hematology
    6. Pediatric or neonatology
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Infusion Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Infusion Systems Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Infusion Systems is a company that provides software and services to healthcare providers. The company's products include patient management software, medication administration systems, and clinical decision support tools. Infusion Systems also offers consulting services to healthcare providers.

Some of the key players operating in the infusion systems market are Competitive scenario, B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, Terumo.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Infusion Systems Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Infusion Systems Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Infusion Systems Market - Supply Chain
   4.5. Global Infusion Systems Market Forecast
      4.5.1. Infusion Systems Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Infusion Systems Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Infusion Systems Market Absolute $ Opportunity

5. Global Infusion Systems Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Infusion Systems Market Size and Volume Forecast by Type
      5.3.1. General purpose or volumetric pumps
      5.3.2. Syringe drivers
      5.3.3. Patient controlled analgesia pumps
      5.3.4. Ambulatory pumps
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Infusion Systems Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Infusion Systems Market Size and Volume Forecast by Application
      6.3.1. Analgesia or pain management
      6.3.2. Diabetes
      6.3.3. Oncology
      6.3.4. Gastroenterology
      6.3.5. Hematology
      6.3.6. Pediatric or neonatology
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Infusion Systems Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Infusion Systems Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Infusion Systems Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Infusion Systems Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Infusion Systems Demand Share Forecast, 2019-2029

9. North America Infusion Systems Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Infusion Systems Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Infusion Systems Market Size and Volume Forecast by Application
      9.4.1. Analgesia or pain management
      9.4.2. Diabetes
      9.4.3. Oncology
      9.4.4. Gastroenterology
      9.4.5. Hematology
      9.4.6. Pediatric or neonatology
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Infusion Systems Market Size and Volume Forecast by Type
      9.7.1. General purpose or volumetric pumps
      9.7.2. Syringe drivers
      9.7.3. Patient controlled analgesia pumps
      9.7.4. Ambulatory pumps
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Infusion Systems Demand Share Forecast, 2019-2029

10. Latin America Infusion Systems Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Infusion Systems Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Infusion Systems Market Size and Volume Forecast by Application
      10.4.1. Analgesia or pain management
      10.4.2. Diabetes
      10.4.3. Oncology
      10.4.4. Gastroenterology
      10.4.5. Hematology
      10.4.6. Pediatric or neonatology
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Infusion Systems Market Size and Volume Forecast by Type
      10.7.1. General purpose or volumetric pumps
      10.7.2. Syringe drivers
      10.7.3. Patient controlled analgesia pumps
      10.7.4. Ambulatory pumps
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Infusion Systems Demand Share Forecast, 2019-2029

11. Europe Infusion Systems Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Infusion Systems Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Infusion Systems Market Size and Volume Forecast by Application
      11.4.1. Analgesia or pain management
      11.4.2. Diabetes
      11.4.3. Oncology
      11.4.4. Gastroenterology
      11.4.5. Hematology
      11.4.6. Pediatric or neonatology
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Infusion Systems Market Size and Volume Forecast by Type
      11.7.1. General purpose or volumetric pumps
      11.7.2. Syringe drivers      11.7.3. Patient controlled analgesia pumps
      11.7.4. Ambulatory pumps
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Infusion Systems Demand Share, 2019-2029

12. Asia Pacific Infusion Systems Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Infusion Systems Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Infusion Systems Market Size and Volume Forecast by Application
      12.4.1. Analgesia or pain management
      12.4.2. Diabetes
      12.4.3. Oncology
      12.4.4. Gastroenterology
      12.4.5. Hematology
      12.4.6. Pediatric or neonatology
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Infusion Systems Market Size and Volume Forecast by Type
      12.7.1. General purpose or volumetric pumps
      12.7.2. Syringe drivers
      12.7.3. Patient controlled analgesia pumps
      12.7.4. Ambulatory pumps
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Infusion Systems Demand Share, 2019-2029

13. Middle East & Africa Infusion Systems Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Infusion Systems Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Infusion Systems Market Size and Volume Forecast by Application
      13.4.1. Analgesia or pain management
      13.4.2. Diabetes
      13.4.3. Oncology
      13.4.4. Gastroenterology
      13.4.5. Hematology
      13.4.6. Pediatric or neonatology
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Infusion Systems Market Size and Volume Forecast by Type
      13.7.1. General purpose or volumetric pumps
      13.7.2. Syringe drivers
      13.7.3. Patient controlled analgesia pumps
      13.7.4. Ambulatory pumps
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Infusion Systems Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Infusion Systems Market: Market Share Analysis
   14.2. Infusion Systems Distributors and Customers
   14.3. Infusion Systems Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Competitive scenario
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. B. Braun Melsungen
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Baxter
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. BD
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Fresenius Kabi
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Hospira
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. JMS
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Nipro
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Terumo
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us